Seizures in COVID-19: the relationship between biomarkers and prognosis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Lu H, Stratton CW, Tang YW (2020) Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol 92(4):401–402. https://doi.org/10.1002/jmv.25678
WHO WHO. (2020) Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance, 28 January 2020. World Health Organization.
Rothan HA, Byrareddy SN (2020) The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun 109:102433. https://doi.org/10.1016/j.jaut.2020.102433
Zhou Z, Kang H, Li S, Zhao X (2020) Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. J Neurol 267(8):2179–2184. https://doi.org/10.1007/s00415-020-09929-7
Bohmwald K, Gálvez NMS, Ríos M, Kalergis AM (2018) Neurologic alterations due to respiratory virus infections. Front Cell Neurosci 12:386. https://doi.org/10.3389/fncel.2018.00386
Narula N, Joseph R, Katyal N, Daouk A, Acharya S, Avula A et al (2020) Seizure and COVID-19: association and review of potential mechanism. Neurol Psychiatry Brain Res 38:49–53. https://doi.org/10.1016/j.npbr.2020.10.001
Mao L, Wang M, Chen S, He Q, Chang J, Hong C, et al. (2020) Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. MedRxiv.
Emami A, Fadakar N, Akbari A, Lotfi M, Farazdaghi M, Javanmardi F et al (2020) Seizure in patients with COVID-19. Neurol Sci 41(11):3057–3061. https://doi.org/10.1007/s10072-020-04731-9
Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J et al (2020) A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis 94:55–58. https://doi.org/10.1016/j.ijid.2020.03.062
ilae: seizures in covid-19,. (2020) https://www.ilae.org/files/dmfile/Seizures-in-COVID-19.pdf. Accessed 17 Dec 2021.
Elgamasy S, Kamel MG, Ghozy S, Khalil A, Morra ME, Islam SMS (2020) First case of focal epilepsy associated with SARS-coronavirus-2. J Med Virol 92(10):2238–2242. https://doi.org/10.1002/jmv.26113
Hepburn M, Mullaguri N, George P, Hantus S, Punia V, Bhimraj A et al (2021) Acute symptomatic seizures in critically ill patients with COVID-19: is there an association? Neurocrit Care 34(1):139–143. https://doi.org/10.1007/s12028-020-01006-1
Kadono Y, Nakamura Y, Ogawa Y, Yamamoto S, Kajikawa R, Nakajima Y et al (2020) A case of COVID-19 infection presenting with a seizure following severe brain edema. Seizure 80:53–55. https://doi.org/10.1016/j.seizure.2020.06.015
Lyons S, O’Kelly B, Woods S, Rowan C, Brady D, Sheehan G et al (2020) Seizure with CSF lymphocytosis as a presenting feature of COVID-19 in an otherwise healthy young man. Seizure 80:113–114. https://doi.org/10.1016/j.seizure.2020.06.010
Efe IE, Aydin OU, Alabulut A, Celik O, Aydin K (2020) COVID-19-associated encephalitis mimicking glial tumor. World Neurosurg 140:46–48. https://doi.org/10.1016/j.wneu.2020.05.194
Haddad S, Tayyar R, Risch L, Churchill G, Fares E, Choe M et al (2020) Encephalopathy and seizure activity in a COVID-19 well controlled HIV patient. IDCases 21:e00814. https://doi.org/10.1016/j.idcr.2020.e00814
Farhadian S, Glick LR, Vogels CBF, Thomas J, Chiarella J, Casanovas-Massana A et al (2020) Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19. BMC Neurol 20(1):248. https://doi.org/10.1186/s12883-020-01812-2
Kabashneh S, Ali H, Alkassis S (2020) Multi-organ failure in a patient with diabetes due to COVID-19 with clear lungs. Cureus 12(5):e8147. https://doi.org/10.7759/cureus.8147
Balloy G, Leclair-Visonneau L, Péréon Y, Magot A, Peyre A, Mahé PJ et al (2020) Non-lesional status epilepticus in a patient with coronavirus disease 2019. Clin Neurophysiol 131(8):2059–2061. https://doi.org/10.1016/j.clinph.2020.05.005
Abdulsalam MA, Abdulsalam AJ, Shehab D (2020) Generalized status epilepticus as a possible manifestation of COVID-19. Acta Neurol Scand 142(4):297–298. https://doi.org/10.1111/ane.13321
Gómez-Enjuto S, Hernando-Requejo V, Lapeña-Motilva J, Ogando-Durán G, Fouz-Ruiz D, Domingo-García J et al (2020) Verapamil as treatment for refractory status epilepticus secondary to PRES syndrome on a SARS-Cov-2 infected patient. Seizure 80:157–158. https://doi.org/10.1016/j.seizure.2020.06.008
Somani S, Pati S, Gaston T, Chitlangia A, Agnihotri S (2020) De Novo Status Epilepticus in patients with COVID-19. Ann Clin Transl Neurol 7(7):1240–1244. https://doi.org/10.1002/acn3.51071
Pinna P, Grewal P, Hall JP, Tavarez T, Dafer RM, Garg R et al (2020) Neurological manifestations and COVID-19: experiences from a tertiary care center at the Frontline. J Neurol Sci 415:116969. https://doi.org/10.1016/j.jns.2020.116969
Radmard S, Epstein SE, Roeder HJ, Michalak AJ, Shapiro SD, Boehme A et al (2020) Inpatient neurology consultations during the onset of the SARS-CoV-2 New York city pandemic: a single center case series. Front Neurol 11:805. https://doi.org/10.3389/fneur.2020.00805
Nalleballe K, Reddy Onteddu S, Sharma R, Dandu V, Brown A, Jasti M et al (2020) Spectrum of neuropsychiatric manifestations in COVID-19. Brain Behav Immun 88:71–74. https://doi.org/10.1016/j.bbi.2020.06.020
Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE et al (2014) ILAE official report: a practical clinical definition of epilepsy. Epilepsia 55(4):475–482. https://doi.org/10.1111/epi.12550
Beghi E, Carpio A, Forsgren L, Hesdorffer DC, Malmgren K, Sander JW et al (2010) Recommendation for a definition of acute symptomatic seizure. Epilepsia 51(4):671–675. https://doi.org/10.1111/j.1528-1167.2009.02285.x
CAN USTA N. Epileptic Seizures Observed in Hospitalized COVID-19 Patients. Epilepsi: Journal of the Turkish Epilepsi Society. 2021;27(4).
Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E, Sánchez-Larsen Á, Layos-Romero A, García-García J et al (2020) Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology 95(8):e1060–e1070. https://doi.org/10.1212/wnl.0000000000009937
Gadi N, Wu SC, Spihlman AP, Moulton VR (2020) What’s sex got to do with COVID-19? Gender-based differences in the host immune response to coronaviruses. Front Immunol 11:2147. https://doi.org/10.3389/fimmu.2020.02147
Kopel J, Perisetti A, Roghani A, Aziz M, Gajendran M, Goyal H (2020) Racial and gender-based differences in COVID-19. Front Public Health 8:418. https://doi.org/10.3389/fpubh.2020.00418
Muñoz-Price LS, Nattinger AB, Rivera F, Hanson R, Gmehlin CG, Perez A et al (2020) Racial disparities in incidence and outcomes among patients with COVID-19. JAMA Netw Open 3(9):e2021892. https://doi.org/10.1001/jamanetworkopen.2020.21892
Santesmasses D, Castro JP, Zenin AA, Shindyapina AV, Gerashchenko MV, Zhang B et al (2020) COVID-19 is an emergent disease of aging. Aging Cell 19(10):e13230. https://doi.org/10.1111/acel.13230
Tazerji SS, Shahabinejad F, Tokasi M, Rad MA, Khan MS, Safdar M et al (2022) Global data analysis and risk factors associated with morbidity and mortality of COVID-19. Gene Rep 26:101505. https://doi.org/10.1016/j.genrep.2022.101505
Asadi-Pooya AA, Kouhanjani MF, Nemati H, Emami A, Javanmardi F (2021) A follow-up study of patients with COVID-19 presenting with seizures. Epilepsy Behav 122:108207. https://doi.org/10.1016/j.yebeh.2021.108207
Danoun OA, Zillgitt A, Hill C, Zutshi D, Harris D, Osman G et al (2021) Outcomes of seizures, status epilepticus, and EEG findings in critically ill patient with COVID-19. Epilepsy Behav 118:107923. https://doi.org/10.1016/j.yebeh.2021.107923
Sanchez-Larsen A, Conde-Blanco E, Viloria-Alebesque A, Sánchez-Vizcaíno Buendía C, Espinosa Oltra T, Alvarez-Noval A et al (2021) COVID-19 prevalence and mortality in people with epilepsy: a nation-wide multicenter study. Epilepsy Behav 125:108379. https://doi.org/10.1016/j.yebeh.2021.108379
Asadi-Pooya AA, Emami A, Akbari A, Javanmardi F (2021) COVID-19 presentations and outcome in patients with epilepsy. Acta Neurol Scand 143(6):624–628. https://doi.org/10.1111/ane.13404
Vossler DG (2021) COVID-19 incidence and death rate in epilepsy: too early to tell? Epilepsy Curr 21(4):261–263. https://doi.org/10.1177/15357597211014195
Daniels H, Lacey AS, Mikadze D, Akbari A, Fonferko-Shadrach B, Hollinghurst J et al (2022) Epilepsy mortality in Wales during COVID-19. Seizure 94:39–42. https://doi.org/10.1016/j.seizure.2021.11.017
Liu J, Li S, Liu J, Liang B, Wang X, Wang H et al (2020) Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine 55:102763. https://doi.org/10.1016/j.ebiom.2020.102763
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054–1062. https://doi.org/10.1016/s0140-6736(20)30566-3
Han Y, Zhang H, Mu S, Wei W, Jin C, Tong C et al (2020) Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study. Aging (Albany NY) 12(12):11245–11258. https://doi.org/10.18632/aging.103372
Liu F, Li L, Xu M, Wu J, Luo D, Zhu Y et al (2020) Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol 127:104370. https://doi.org/10.1016/j.jcv.2020.104370
Cheng L, Li H, Li L, Liu C, Yan S, Chen H et al (2020) Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. J Clin Lab Anal 34(10):e23618. https://doi.org/10.1002/jcla.23618
Ahmad I, Rathore FA (2020) Neurological manifestations and complications of COVID-19: a literature review. J Clin Neurosci 77:8–12. https://doi.org/10.1016/j.jocn.2020.05.017
Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C et al (2020) Neurologic features in severe SARS-CoV-2 Infection. N Engl J Med 382(23):2268–2270. https://doi.org/10.1056/NEJMc2008597
Elhadi M, Alsoufi A, Abusalama A, Alkaseek A, Abdeewi S, Yahya M et al (2021) Epidemiology, outcomes, and utilization of intensive care unit resources for critically ill COVID-19 patients in Libya: a prospective multi-center cohort study. PLoS ONE 16(4):e0251085. https://doi.org/10.1371/journal.pone.0251085
Tan L, Wang Q, Zhang D, Ding J, Huang Q, Tang YQ et al (2020) Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther 5(1):33. https://doi.org/10.1038/s41392-020-0148-4